Lipocalin homologs
AssigneeZymoGenetics, Inc.
InventorDarrell C. Conklin
Life of this patent
Estimating the term…
Abstract
The present invention is directed to polynucleotides and polypeptides for a novel member of the lipocalin family. The expression of this novel polynucleotide is restricted to testis and mammary gland, particularly breast tumor tissue. The polypeptide has been designated zlipo1. The present invention also includes antibodies to the zlipo1 polypeptides.
Claims5
An isolated polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:
- 2 from amino acid residue 1 or 17 to residue 170.
A pharmaceutical composition comprising a polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:
- 2 from residue 1 or 17 to residue 170, in combination with a pharmaceutically acceptable vehicle.
A fusion protein comprising a first polypeptide comprising a sequence of amino acid residues as shown in SEQ ID NO:
- 2 from residue 1 or 17 to residue 170 and a second moiety.
Dependencies are inferred from the claim text.